These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3016580)

  • 1. Interaction of dimeric and monomeric enkephalins with NG108-15 hybrid cells. A kinetic analysis.
    Krumins SA; Lutz RA; Costa T; Rodbard D
    Neurochem Res; 1986 Jun; 11(6):839-50. PubMed ID: 3016580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of the binding of dimeric and monomeric enkephalins to neuroblastoma-glioma NG108-15 cells.
    Krumins SA; Rodbard D
    J Neurochem; 1985 Jul; 45(1):101-7. PubMed ID: 2987405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric pentapeptide enkephalin: a novel probe of delta opiate receptors.
    Costa T; Shimohigashi Y; Krumins SA; Munson PJ; Rodbard D
    Life Sci; 1982 Oct; 31(15):1625-32. PubMed ID: 6292643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased affinity of dimeric enkephalins is not dependent on receptor density.
    Lutz RA; Costa T; Cruciani RA; Jacobson AE; Rice KC; Burke TR; Krumins SA; Rodbard D
    Neuropeptides; 1985 Apr; 6(2):167-74. PubMed ID: 2987746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of enkephalin activity in neuroblastoma X glioma NG108-15 hybrid cells by phospholipases.
    Law PY; Griffin MT; Koehler JE; Loh HH
    J Neurochem; 1983 Jan; 40(1):267-75. PubMed ID: 6294248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of long-term treatment of NG108-15 cells with penta- and tetrapeptide enkephalin dimers on opioid receptor binding and cyclic AMP (cAMP) levels.
    Krumins SA
    Cell Mol Neurobiol; 1987 Jun; 7(2):221-8. PubMed ID: 2820579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes.
    Cruciani RA; Lutz RA; Munson PJ; Rodbard D
    J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1, D-Ala2, Leu5-enkephalin binding.
    Benyhe S; Tóth G; Kevei J; Szücs M; Borsodi A; Di Gléria K; Szécsi J; Süli-Vargha H; Medzihradszky K
    Neurochem Res; 1985 May; 10(5):627-35. PubMed ID: 2989719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
    Wolozin BL; Pasternak GW
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [3H][2-D-penicillamine, 5-D-penicillamine]-enkephalin binding to delta opiate receptors in the rat brain and neuroblastoma--glioma hybrid cell line (NG 108-15).
    Akiyama K; Gee KW; Mosberg HI; Hruby VJ; Yamamura HI
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2543-7. PubMed ID: 2986120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine.
    Kondo M; Kodama H; Costa T; Shimohigashi Y
    Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of three separate guanine nucleotide-binding proteins that interact with the delta-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells.
    Roerig SC; Loh HH; Law PY
    Mol Pharmacol; 1992 May; 41(5):822-31. PubMed ID: 1317000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):677-87. PubMed ID: 2993509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
    Mosberg HI; Hurst R; Hruby VJ; Gee K; Yamamura HI; Galligan JJ; Burks TF
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):5871-4. PubMed ID: 6310598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid receptor binding in rat spinal cord.
    Krumins SA
    Neurochem Res; 1987 Mar; 12(3):231-5. PubMed ID: 3035399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metkephamid (Tyr-D-ala-Gly-Phe-N(Me)Met-NH2), a potent opioid peptide: receptor binding and analgesic properties.
    Burkhardt C; Frederickson RC; Pasternak GW
    Peptides; 1982; 3(5):869-71. PubMed ID: 6294639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL; Recht LD; Pasternak GW
    Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors.
    Bowen WD; Kelemen M; Huey R; Stewart D
    NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental attempt to simulate receptor site environment. A 500-MHz 1H nuclear magnetic resonance study of enkephalin amides.
    Temussi PA; Tancredi T; Pastore A; Castiglione-Morelli MA
    Biochemistry; 1987 Dec; 26(24):7856-63. PubMed ID: 2827761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM
    Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.